紫云英苷抑制APP/PS1小鼠大脑皮质神经元凋亡 [PDF]
目的探讨紫云英苷 (AST)对APP/PS1转基因小鼠大脑皮质神经元凋亡的影响。方法将18只6月龄雄性APP/PS1转基因小鼠随机分为APP/PS1、APP/PS1+40 mg/kg AST、APP/PS1+20 mg/kg DNP (Donepezil, DNP)三组,每组各6只动物。同时另选6只同月龄C57BL/6雄性小鼠作为正常对照组 (Control)。腹腔注射给药AST,每日一次,连续给药一个月后,Tunel染色法检测APP/PS1小鼠大脑皮质内神经元凋亡情况;免疫荧光染色法检测APP ...
王姝涵 +7 more
doaj +3 more sources
紫云英苷诱导自噬减轻APP/PS1转基因小鼠皮质内神经元损伤及老年斑沉积 [PDF]
目的探讨紫云英苷(AST)对APP/PS1转基因小鼠脑皮质神经元及Aβ斑块的影响。方法将24只8月龄雄性APP/PS1转基因小鼠随机分为APP/PS1组、10 mg/kg AST(APP/PS1+AST 10)组、20 mg/kg AST(APP/PS1+AST 20)组、40 mg/kg AST(APP/PS1+AST 40)组,每组各6只。6只同月龄C57BL/6雄性小鼠作为对照组(WT组)。AST药物连续腹腔注射一个月后,采用免疫荧光染色法观察小鼠脑皮质内Aβ斑块沉积情况 ...
杨翠珠 +6 more
doaj +3 more sources
紫云英苷调控炎性痛模型小鼠L4-5脊髓背角星形胶质细胞自噬与凋亡
目的探究紫云英苷(AST)对完全弗氏佐剂(CFA)诱发的炎性痛小鼠L4-5脊髓背角星形胶质细胞自噬及凋亡的影响。方法将24只雄性6月龄C57BL/6小鼠随机分为正常组(control)、生理盐水组(saline)、CFA模型组、CFA+AST组,每组6只小鼠。于小鼠右侧腓骨外踝窝注射10 µL CFA建立炎性痛小鼠模型。saline组小鼠注射等量生理盐水。CFA+AST组小鼠在疼痛造模成功后腹腔注射给药60 mg/kg AST,每日一次,连续给药21 d。采用多重免疫荧光染色法检测各组小鼠L4 ...
张维珊 +7 more
doaj
[Synergistic effect of azacitidine with homoharringtonine by activating the c-MYC/DDIT3/PUMA axis in acute myeloid leukemia]. [PDF]
Li J, Huang YQ, Zi J, Song CH, Ge Z.
europepmc +1 more source
[Chinese guideline for diagnosis and management of drug-induced liver injury (2023 version)]. [PDF]
Technology Committee on DILI Prevention and Management +3 more
europepmc +1 more source
Effects of isoprenylcysteine carboxylmethyltransferase silencing on the migration and invasion of tongue squamous cell carcinoma. [PDF]
Zhou N +10 more
europepmc +1 more source
[Analysis of chemical components of Chinese medicine Ligustici Radix by achiral-chiral liquid chromatography-predictive multiple reaction monitoring]. [PDF]
Xu X +6 more
europepmc +1 more source
Asiatic acid improves insulin secretion of β cells in type 2 diabetes through TNF-α/Mfn2 pathway. [PDF]
Li L, Wang W, Xu Q, Huang M.
europepmc +1 more source
Clinical effect of different maintenance doses of caffeine citrate in the treatment of preterm infants requiring assisted ventilation: a pilot multicenter study. [PDF]
Yang Y +33 more
europepmc +1 more source
[Guidelines on the management of cholestasis liver diseases (2021)]. [PDF]
Chinese Society of Hepatology +1 more
europepmc +1 more source

